CAMP4 Therapeutics Corporation IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| CAMP4 Therapeutics Corporation | CAMP - NASDAQ |
$14.00-$16.00 | $11.00 | $11.16 | 6.82 million | 10/11/2024 |
| J.P. Morgan, Leerink Partners, Piper Sandler, William Blair | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2024-09-20 Terms Added 2024-10-07 | ||||||
CAMP4 Therapeutics Corporation Quote & Chart - Click for current quote - CAMP
IPO Boutique aggregates information on public companies and private companies, such as "CAMP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About CAMP4 Therapeutics Corporation (adapted from CAMP4 Therapeutics Corporation prospectus):
They are a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CAMP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.